Pharmacotherapy of female urinary incontinence.
Urinary incontinence is a major clinical problem and a significant cause of disability and dependency in older adults. Overall, the prevalence of urinary incontinence approaches 55% among women aged over 55 years. The past few years have seen significant advances in the pharmacotherapy of overactive bladder and stress incontinence. The review examines the evidence regarding their benefits and side-effects.
Naumann
Gert
G
Department of Obstetrics and Gynaecology, Johannes Gutenberg University, Mainz, Germany.
Koelbl
Heinz
H
D000322:Adrenergic Agonists / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006304:Health Status; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D011788:Quality of Life; D014550:Urinary Incontinence, Stress / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D016387:Women's Health
D000322:Adrenergic Agonists; D000892:Anti-Infective Agents, Urinary; D018680:Cholinergic Antagonists; D004967:Estrogens; D018727:Muscarinic Antagonists